Mental Health App for Cancer Survivors Study
Launched by UNIVERSITY OF WISCONSIN, MADISON · Jun 18, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The "Mental Health App for Cancer Survivors Study" is a clinical trial aimed at helping people who have had head and neck cancer and are experiencing depression. The study is testing a digital app designed to improve mental health over a 6-week period. Participants will use the app regularly and complete surveys to help researchers understand its effectiveness in treating moderate to severe depression.
To be eligible for this study, participants must be at least 22 years old and have a confirmed diagnosis of head and neck cancer. They should also have a score indicating moderate to severe depression on a specific questionnaire. It's important to note that individuals who are currently taking prescription medication for depression, those with severe depression, or those who cannot read and speak English will not be able to join the study. Participants can expect to engage with the app and provide feedback, contributing to valuable research that could benefit future cancer survivors facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • History of HNC confirmed by histopathologic diagnosis. The signed report must be available on electronic health record (EHR) for participants who received treatment or follow-up at University of Wisconsin Carbone Cancer Center (UWCCC). Alternatively, participants must have a printed signed report if received treatment out of UWCCC
- • Age greater than or equal to 22 years at the time of consent
- • Patient Health Questionnaire-9 (PHQ-9) score ≥ 5 and ≤ 19 (moderate and severely moderate depression)
- • Willing to comply with all study procedures and be available for the duration of the study.
- Exclusion Criteria:
- • Unable to read and speak English.
- • Utilization of prescription medicine for depression.
- • Patient Health Questionnaire-9 (PHQ-9) score of greater than or equal to 20 (severe depression)
- • Patient Health Questionnaire-9 (PHQ-9) score greater than or equal to 1 on the suicidal question (question 9)
- • Pregnant people
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
Patients applied
Trial Officials
Earlise Ward, MS, PhD, LP
Principal Investigator
University of Wisconsin, Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported